Quillivant XR 25 MG/5 ML susp 150ML
Ended Awarded Last action
- Contract number
- SPE2DR26FA0KW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,864
Award facts
- Contract value 100% obligated
- $1,864.35 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,864.35 for Quillivant XR 25 mg/5 ml suspension (150 ml) with a firm fixed price and completion date of December 4, 2025. This non-set-aside competitive award was issued on December 3, 2025, with performance to be completed at the company's Conshohocken, Pennsylvania location. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical vendor that supplies an extensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. The company's federal contract portfolio demonstrates consistent capability to meet procurement requirements through open competition, with delivery orders spanning small-value transactions to substantial orders exceeding $45,000. This particular award for Quillivant XR—a medication used to treat attention-deficit/hyperactivity disorder—exemplifies the company's role as a key provider of specialized medications across multiple therapeutic domains within the DLA's medical supply chain infrastructure.
Quick answers
Who was awarded contract SPE2DR26FA0KW?
SPE2DR26FA0KW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 3, 2025.
How much is contract SPE2DR26FA0KW worth?
The government has obligated $1,864 on SPE2DR26FA0KW.
Is contract SPE2DR26FA0KW an order under another contract?
Yes. SPE2DR26FA0KW is a delivery order under SPE2DR25D2100, an indefinite delivery contract.
Was contract SPE2DR26FA0KW competed?
The extent of competition for SPE2DR26FA0KW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award